Transcriptionally Conditional Recurrent Neural Network for De Novo Drug Design.

Journal: Journal of chemical information and modeling
PMID:

Abstract

Computational molecular generation methods that generate chemical structures from gene expression profiles have been actively developed for de novo drug design. However, most omics-based methods involve complex models consisting of multiple neural networks, which require pretraining. In this study, we propose a straightforward molecular generation method called GxRNN (gene expression profile-based recurrent neural network), employing a single recurrent neural network (RNN) that necessitates no pretraining for omics-based drug design. Specifically, our method utilizes the desired gene expression profile as input for the RNN, conditioning it to generate molecules likely to induce a similar profile. In a case study involving ten target proteins, GxRNN exhibited superior structural reproducibility of known ligands, surpassing several existing methods. This advancement positions our proposed method as a promising tool for facilitating de novo drug design.

Authors

  • Yuki Matsukiyo
    Department of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502, Japan.
  • Atsushi Tengeiji
    Modality Research Laboratories I, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa, Tokyo 140-8710, Japan.
  • Chen Li
    School of Computer Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yoshihiro Yamanishi
    Division of System Cohort, Multi-Scale Research Center for Medical Science, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 812-8582, Japan. yamanishi@bioreg.kyushu-u.ac.jp.